Pharma digs in on changes it wants from Trump administration
By Deena Beasley SAN FRANCISCO (Reuters) – The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on “fixing” a Biden-era law allowing the Medicare health plan to negotiate prices
Geberit shares fall following earnings
Investing.com — Geberit AG shares declined Thursday after the Swiss plumbing products company reported mixed earnings for 2024. Despite achieving a 2.5% currency-adjusted increase in net sales, the firm highlighted several challenges. The company revealed that net sales in Swiss francs remained
Carlyle considers selling British fund network Calastone
Investing.com — Carlyle, the U.S. buyout group, is reportedly preparing to explore a sale of its British funds network and data business, Calastone, according to sources familiar with the matter. The London-based business, which serves as a marketplace for trading
PNC Financial earnings beat by $0.47, revenue topped estimates
Investing.com – PNC Financial (NYSE: PNC) reported fourth quarter EPS of $3.77, $0.47 better than the analyst estimate of $3.30. Revenue for the quarter came in at $5.57B versus the consensus estimate of $5.48B. PNC Financial’s stock price closed at $200.44.
UnitedHealth’s quarterly revenue misses on weakness in insurance unit
(Reuters) – UnitedHealth Group (NYSE:UNH) reported fourth-quarter revenue below Wall Street estimates on Thursday, hurt by weakness in its health insurance unit, sending the healthcare conglomerate’s shares down about 3% in premarket trading. The company’s results come a month after Brian